Pharmacokinetics and Safety of Atogepant Co‐administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open‐Label, Drug‐Drug Interaction Study

Ähnliche Einträge

• A 2‐Part, Open‐Label, Phase 1 Bioequivalence and Food‐Effect Study of Ubrogepant in Healthy Adult Participants
  von: Ramesh Boinpally, et al.
  Veröffentlicht: (2025)
• Effect of a High‐Fat Meal on the Pharmacokinetics of an Immediate Release Atogepant Tablet
  von: Ramesh R. Boinpally, et al.
  Veröffentlicht: (2024)
• Effects of Quinidine or Rifampin Co‐administration on the Single‐Dose Pharmacokinetics and Safety of Rilzabrutinib (PRN1008) in Healthy Participants
  von: Christian Rask‐Madsen, et al.
  Veröffentlicht: (2024)
• Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants
  von: Matthias Hoch, et al.
  Veröffentlicht: (2025)
• Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants
  von: Shichang Miao, et al.
  Veröffentlicht: (2024)